Taken together, these data demonstrate that CD4+ T cell help is not required for the therapeutic immune responses generated by SA-4-1BBL-based vaccination and the lack of CD4+ T cell role is independent of TAAs and tumor models used in this study. This evidence concerns the gene CD4 and neoplasm.